Reply

Gastroenterology. 2020 Mar;158(4):1177-1178. doi: 10.1053/j.gastro.2019.12.024. Epub 2020 Jan 3.

Authors

Silvio Danese¹, Jordi Rimola², Jenifer Siegelman³

Affiliations

¹ IBD Center, Humanitas Clinical and Research Center, Humanitas University, Rozzano, Milan, Italy.
² Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
³ Takeda Development Centre Americas Inc., Cambridge, Massachusetts.

PMID: 31911101
DOI: 10.1053/j.gastro.2019.12.024

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Crohn Disease*
Humans

Substances

Antibodies, Monoclonal, Humanized
vedolizumab